BPC-157, a peptide shown to be effective in animal studies for treating diseases of the GI tract and aiding in the repair of musculoskeletal injuries. While human studies remain limited and the therapy is not FDA-approved, an increasing body of anecdotal evidence suggests significant efficacy in specific patient populations with a minimal potential for side effects. As the darling of the biohacking, bodybuilding, and performance-enhancing commkities, BPC-157 has been extensively used overseas in athletics, nootropic, and regenerative spaces for years. It is now rapidly becoming a staple in the fields of regenerative medicine, anti-aging medicine, and functional medicine, showcasing its broad applicability and promising results in health optimization and recovery.